世界の免疫抑制剤API市場予測（～2028年）：コルチコステロイド、ヤヌスキナーゼ阻害剤、カルシニューリン阻害剤、mTOR阻害剤、IMDH阻害剤、生物製剤、モノクローナル抗体

• 英文タイトル：Global Immunosuppressants API Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8852 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

免疫抑制剤API市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の免疫抑制剤APIの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 免疫抑制剤API市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・コルチコステロイド、ヤヌスキナーゼ阻害剤、カルシニューリン阻害剤、mTOR阻害剤、IMDH阻害剤、生物製剤、モノクローナル抗体 用途別セグメントは次のように区分されます。 ・自己免疫疾患、臓器移植、その他 世界の免疫抑制剤API市場の主要な市場プレーヤーは以下のとおりです。 ・Biocon Ltd.、NATCO Pharma Limited、Triveni Interchem Private Limited、Concord Biotech Ltd.、RPG Life Sciences Limited、Jiangsu Jiuyang Bio-PharmaceuticalCo. Ltd、Chunghwa Chemical Synthesis & BiotechCo. Ltd.、AbbVie Inc.、Pfizer Inc.、Zhejiang Hisun PharmaceuticalCo Ltd 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、免疫抑制剤API製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な免疫抑制剤APIメーカーの企業概要、2019年～2022年までの免疫抑制剤APIの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な免疫抑制剤APIメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別免疫抑制剤APIの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの免疫抑制剤APIの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での免疫抑制剤API市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および免疫抑制剤APIの産業チェーンを掲載しています。 ・第13、14、15章では、免疫抑制剤APIの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Biocon Ltd.、NATCO Pharma Limited、Triveni Interchem Private Limited、Concord Biotech Ltd.、RPG Life Sciences Limited、Jiangsu Jiuyang Bio-PharmaceuticalCo. Ltd、Chunghwa Chemical Synthesis & BiotechCo. Ltd.、AbbVie Inc.、Pfizer Inc.、Zhejiang Hisun PharmaceuticalCo Ltd ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：コルチコステロイド、ヤヌスキナーゼ阻害剤、カルシニューリン阻害剤、mTOR阻害剤、IMDH阻害剤、生物製剤、モノクローナル抗体 ・用途別分析2017年-2028年：自己免疫疾患、臓器移植、その他 ・免疫抑制剤APIの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・免疫抑制剤APIのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・免疫抑制剤APIのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・免疫抑制剤APIの南米市場規模2017年-2028年：ブラジル、アルゼンチン ・免疫抑制剤APIの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Immunosuppressants API market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Immunosuppressants API market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Autoimmune Disease accounting for % of the Immunosuppressants API global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Corticosteroids segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Immunosuppressants API include Biocon Ltd., NATCO Pharma Limited, Triveni Interchem Private Limited, Concord Biotech Ltd., and RPG Life Sciences Limited, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Immunosuppressants API market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Corticosteroids
Janus kinase inhibitor
Calcineurin inhibitors
mTOR inhibitor
IMDH inhibitor
Biologics
Monoclonal antibodies
Market segment by Application can be divided into
Autoimmune Disease
Organ Transplant
Others
The key market players for global Immunosuppressants API market are listed below:
Biocon Ltd.
NATCO Pharma Limited
Triveni Interchem Private Limited
Concord Biotech Ltd.
RPG Life Sciences Limited
Jiangsu Jiuyang Bio-PharmaceuticalCo. Ltd
Chunghwa Chemical Synthesis & BiotechCo. Ltd.
AbbVie Inc.
Pfizer Inc.
Zhejiang Hisun PharmaceuticalCo Ltd
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Immunosuppressants API product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Immunosuppressants API, with price, sales, revenue and global market share of Immunosuppressants API from 2019 to 2022.
Chapter 3, the Immunosuppressants API competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Immunosuppressants API breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Immunosuppressants API market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Immunosuppressants API.
Chapter 13, 14, and 15, to describe Immunosuppressants API sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Immunosuppressants API Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Immunosuppressants API Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Corticosteroids
1.2.3 Janus kinase inhibitor
1.2.4 Calcineurin inhibitors
1.2.5 mTOR inhibitor
1.2.6 IMDH inhibitor
1.2.7 Biologics
1.2.8 Monoclonal antibodies
1.3 Market Analysis by Application
1.3.1 Overview: Global Immunosuppressants API Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Autoimmune Disease
1.3.3 Organ Transplant
1.3.4 Others
1.4 Global Immunosuppressants API Market Size & Forecast
1.4.1 Global Immunosuppressants API Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Immunosuppressants API Sales in Volume (2017-2028)
1.4.3 Global Immunosuppressants API Price (2017-2028)
1.5 Global Immunosuppressants API Production Capacity Analysis
1.5.1 Global Immunosuppressants API Total Production Capacity (2017-2028)
1.5.2 Global Immunosuppressants API Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Immunosuppressants API Market Drivers
1.6.2 Immunosuppressants API Market Restraints
1.6.3 Immunosuppressants API Trends Analysis
2 Manufacturers Profiles
2.1 Biocon Ltd.
2.1.1 Biocon Ltd. Details
2.1.2 Biocon Ltd. Major Business
2.1.3 Biocon Ltd. Immunosuppressants API Product and Services
2.1.4 Biocon Ltd. Immunosuppressants API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 NATCO Pharma Limited
2.2.1 NATCO Pharma Limited Details
2.2.2 NATCO Pharma Limited Major Business
2.2.3 NATCO Pharma Limited Immunosuppressants API Product and Services
2.2.4 NATCO Pharma Limited Immunosuppressants API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Triveni Interchem Private Limited
2.3.1 Triveni Interchem Private Limited Details
2.3.2 Triveni Interchem Private Limited Major Business
2.3.3 Triveni Interchem Private Limited Immunosuppressants API Product and Services
2.3.4 Triveni Interchem Private Limited Immunosuppressants API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Concord Biotech Ltd.
2.4.1 Concord Biotech Ltd. Details
2.4.2 Concord Biotech Ltd. Major Business
2.4.3 Concord Biotech Ltd. Immunosuppressants API Product and Services
2.4.4 Concord Biotech Ltd. Immunosuppressants API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 RPG Life Sciences Limited
2.5.1 RPG Life Sciences Limited Details
2.5.2 RPG Life Sciences Limited Major Business
2.5.3 RPG Life Sciences Limited Immunosuppressants API Product and Services
2.5.4 RPG Life Sciences Limited Immunosuppressants API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Jiangsu Jiuyang Bio-PharmaceuticalCo. Ltd
2.6.1 Jiangsu Jiuyang Bio-PharmaceuticalCo. Ltd Details
2.6.2 Jiangsu Jiuyang Bio-PharmaceuticalCo. Ltd Major Business
2.6.3 Jiangsu Jiuyang Bio-PharmaceuticalCo. Ltd Immunosuppressants API Product and Services
2.6.4 Jiangsu Jiuyang Bio-PharmaceuticalCo. Ltd Immunosuppressants API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Chunghwa Chemical Synthesis & BiotechCo. Ltd.
2.7.1 Chunghwa Chemical Synthesis & BiotechCo. Ltd. Details
2.7.2 Chunghwa Chemical Synthesis & BiotechCo. Ltd. Major Business
2.7.3 Chunghwa Chemical Synthesis & BiotechCo. Ltd. Immunosuppressants API Product and Services
2.7.4 Chunghwa Chemical Synthesis & BiotechCo. Ltd. Immunosuppressants API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 AbbVie Inc.
2.8.1 AbbVie Inc. Details
2.8.2 AbbVie Inc. Major Business
2.8.3 AbbVie Inc. Immunosuppressants API Product and Services
2.8.4 AbbVie Inc. Immunosuppressants API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Pfizer Inc.
2.9.1 Pfizer Inc. Details
2.9.2 Pfizer Inc. Major Business
2.9.3 Pfizer Inc. Immunosuppressants API Product and Services
2.9.4 Pfizer Inc. Immunosuppressants API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Zhejiang Hisun PharmaceuticalCo Ltd
2.10.1 Zhejiang Hisun PharmaceuticalCo Ltd Details
2.10.2 Zhejiang Hisun PharmaceuticalCo Ltd Major Business
2.10.3 Zhejiang Hisun PharmaceuticalCo Ltd Immunosuppressants API Product and Services
2.10.4 Zhejiang Hisun PharmaceuticalCo Ltd Immunosuppressants API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Immunosuppressants API Breakdown Data by Manufacturer
3.1 Global Immunosuppressants API Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Immunosuppressants API Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Immunosuppressants API
3.4 Market Concentration Rate
3.4.1 Top 3 Immunosuppressants API Manufacturer Market Share in 2021
3.4.2 Top 6 Immunosuppressants API Manufacturer Market Share in 2021
3.5 Global Immunosuppressants API Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Immunosuppressants API Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Immunosuppressants API Market Size by Region
4.1.1 Global Immunosuppressants API Sales in Volume by Region (2017-2028)
4.1.2 Global Immunosuppressants API Revenue by Region (2017-2028)
4.2 North America Immunosuppressants API Revenue (2017-2028)
4.3 Europe Immunosuppressants API Revenue (2017-2028)
4.4 Asia-Pacific Immunosuppressants API Revenue (2017-2028)
4.5 South America Immunosuppressants API Revenue (2017-2028)
4.6 Middle East and Africa Immunosuppressants API Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Immunosuppressants API Sales in Volume by Type (2017-2028)
5.2 Global Immunosuppressants API Revenue by Type (2017-2028)
5.3 Global Immunosuppressants API Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Immunosuppressants API Sales in Volume by Application (2017-2028)
6.2 Global Immunosuppressants API Revenue by Application (2017-2028)
6.3 Global Immunosuppressants API Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Immunosuppressants API Sales by Type (2017-2028)
7.2 North America Immunosuppressants API Sales by Application (2017-2028)
7.3 North America Immunosuppressants API Market Size by Country
7.3.1 North America Immunosuppressants API Sales in Volume by Country (2017-2028)
7.3.2 North America Immunosuppressants API Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Immunosuppressants API Sales by Type (2017-2028)
8.2 Europe Immunosuppressants API Sales by Application (2017-2028)
8.3 Europe Immunosuppressants API Market Size by Country
8.3.1 Europe Immunosuppressants API Sales in Volume by Country (2017-2028)
8.3.2 Europe Immunosuppressants API Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Immunosuppressants API Sales by Type (2017-2028)
9.2 Asia-Pacific Immunosuppressants API Sales by Application (2017-2028)
9.3 Asia-Pacific Immunosuppressants API Market Size by Region
9.3.1 Asia-Pacific Immunosuppressants API Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Immunosuppressants API Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Immunosuppressants API Sales by Type (2017-2028)
10.2 South America Immunosuppressants API Sales by Application (2017-2028)
10.3 South America Immunosuppressants API Market Size by Country
10.3.1 South America Immunosuppressants API Sales in Volume by Country (2017-2028)
10.3.2 South America Immunosuppressants API Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Immunosuppressants API Sales by Type (2017-2028)
11.2 Middle East & Africa Immunosuppressants API Sales by Application (2017-2028)
11.3 Middle East & Africa Immunosuppressants API Market Size by Country
11.3.1 Middle East & Africa Immunosuppressants API Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Immunosuppressants API Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Immunosuppressants API and Key Manufacturers
12.2 Manufacturing Costs Percentage of Immunosuppressants API
12.3 Immunosuppressants API Production Process
12.4 Immunosuppressants API Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Immunosuppressants API Typical Distributors
13.3 Immunosuppressants API Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---